Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Biliary Carcinoma × Gastrointestinal × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1291 Pancreatic Neoplasms 597 Colonic Neoplasms 579 Carcinoma, Hepatocellular 558 Rectal Neoplasms 513 Stomach Neoplasms 485 Esophageal Neoplasms 335 Liver Neoplasms 248 Breast Neoplasms 238 Neoplasms 218 Gastrointestinal Neoplasms 193 Lung Neoplasms 151 Prostatic Neoplasms 120 Barrett Esophagus 118 Colonic Polyps 102 Cholangiocarcinoma 97 Motor Activity 93 Head and Neck Neoplasms 64 Ovarian Neoplasms 61 Adenoma 57 Neoplasm Metastasis 54 Uterine Cervical Neoplasms 51 Colorectal Neoplasms, Hereditary Nonpolyposis 47 Anus Neoplasms 47 Anastomotic Leak 44 Postoperative Complications 43 Esophageal Squamous Cell Carcinoma 43 Carcinoma, Non-Small-Cell Lung 43 Biliary Tract Neoplasms 42 Pain 41

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown

Gastrointestinal

Biliary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡